IRIS
MAZZUCCHELLI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.201
EU - Europa 4.935
AS - Asia 4.039
SA - Sud America 1.131
AF - Africa 192
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 13
AN - Antartide 1
Totale 20.532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.061
SG - Singapore 1.403
UA - Ucraina 1.012
BR - Brasile 966
CN - Cina 755
RU - Federazione Russa 611
DE - Germania 582
IE - Irlanda 567
TR - Turchia 544
SE - Svezia 519
HK - Hong Kong 501
IT - Italia 477
DK - Danimarca 386
VN - Vietnam 278
FI - Finlandia 261
KR - Corea 217
GB - Regno Unito 197
FR - Francia 154
CI - Costa d'Avorio 86
IN - India 82
MX - Messico 65
CA - Canada 61
AR - Argentina 58
ID - Indonesia 51
ZA - Sudafrica 40
JP - Giappone 36
EC - Ecuador 32
BE - Belgio 31
IQ - Iraq 29
PL - Polonia 26
BD - Bangladesh 24
MA - Marocco 23
ES - Italia 21
IR - Iran 21
NL - Olanda 19
PK - Pakistan 18
RO - Romania 18
EU - Europa 17
PE - Perù 16
CO - Colombia 14
AT - Austria 13
EG - Egitto 13
PY - Paraguay 13
VE - Venezuela 13
MY - Malesia 11
CL - Cile 10
KE - Kenya 10
JO - Giordania 9
UZ - Uzbekistan 9
AU - Australia 7
SA - Arabia Saudita 7
AL - Albania 6
CH - Svizzera 6
DZ - Algeria 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AE - Emirati Arabi Uniti 5
TW - Taiwan 5
CR - Costa Rica 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
KZ - Kazakistan 4
OM - Oman 4
TH - Thailandia 4
UY - Uruguay 4
AM - Armenia 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
LB - Libano 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
ET - Etiopia 2
GD - Grenada 2
GR - Grecia 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
TN - Tunisia 2
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
DM - Dominica 1
EE - Estonia 1
GF - Guiana Francese 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LU - Lussemburgo 1
MN - Mongolia 1
Totale 20.522
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.026
Chandler 976
Ashburn 873
Singapore 868
Fairfield 758
Dallas 695
Des Moines 579
Boardman 567
Dublin 567
Hong Kong 495
Wilmington 401
New York 352
Woodbridge 330
Houston 278
Seattle 275
Lawrence 224
Princeton 224
San Mateo 215
Cambridge 207
Beijing 196
Ann Arbor 192
Centro 135
Hefei 134
Moscow 121
Ho Chi Minh City 117
Los Angeles 94
San Diego 90
The Dalles 89
Munich 87
Abidjan 86
São Paulo 86
Buffalo 64
Hanoi 62
Chicago 60
London 47
Redmond 42
Turku 39
Shanghai 36
Brussels 31
Washington 31
Wuhan 30
Mexico City 28
Tokyo 28
Guangzhou 27
Rio de Janeiro 27
Milan 26
Pune 26
Ancona 25
Helsinki 24
Marche 24
Belo Horizonte 23
Warsaw 23
Izmir 21
Brooklyn 20
Santa Clara 20
Turin 19
Columbus 18
Denver 17
Porto 17
Curitiba 16
Salvador 16
Stockholm 16
Atlanta 15
Durban 15
Haiphong 15
Istanbul 15
Rome 15
Baghdad 14
Campinas 14
Frankfurt am Main 14
Montreal 14
Norwalk 14
Phoenix 14
Porto Alegre 14
Brasília 13
Chennai 13
Council Bluffs 13
Jiaxing 13
Salt Lake City 13
Brasov 12
Johannesburg 11
Manchester 11
Quito 11
San Francisco 11
Toronto 11
Biên Hòa 10
Osasco 10
Tampa 10
Amman 9
Ankara 9
Boston 9
Fortaleza 9
Goiânia 9
Guarulhos 9
Orem 9
Seoul 9
Sorocaba 9
Buenos Aires 8
Erbil 8
Guayaquil 8
Totale 12.680
Salva come PNG Salva come JPEG
Nome #
Cellular Modulators of the NRF2/KEAP1 Signaling Pathway in Prostate Cancer 343
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 185
The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer 170
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 148
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 146
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 146
Metabolic phenotype of bladder cancer 146
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 145
Clinical progression of megacalycosis in a girl with a solitary kidney: The lesson learned 144
AT-rich interactive domain 1A protein expression in normal and pathological pregnancies complicated by preeclampsia 144
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 141
2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections 141
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 140
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 136
Secondary neoplasms of the urinary system and male genital organs. 135
Predicting future cancer burden in the United States by artificial neural networks 135
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 129
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 125
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 124
Adipose cannabinoid CB1 receptor expression and adiponectin correlate with microvascular damage in human kidney 124
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 124
Nuclear changes in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer. Morphometric analysis in whole-mount sections. 123
Active surveillance for low-risk prostate cancer. 123
Low HtrA1 expression in patients with long‑standing ulcerative colitis and colorectal cancer 122
Angiogenesis as prognostic factor in small renal tumors 120
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 120
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 119
2005 update on pathology of prostate biopsies with cancer 119
[Interstitial cystitis: minimal diagnostic criteria]. 119
Metabolic Alterations in Renal and Prostate Cancer 119
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 117
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 116
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 116
Analytical and Qualitative Cytology and Histology. Reflection on the past two years. 115
A painful diagnosis 115
Increased VEGF165 expression in HCT116 colon cancer cells after transient transfection with a GFP vector encoding HIF-1 gene. 114
Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. 114
Morphological diagnosis of urothelial neoplasms. 112
[Thin glomerular basement membrane disease]. 112
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 111
Effect of complete androgen blockade on pathologic stage and resection margin status of prostate cancer: Progress pathology report of the Italian PROSIT study 110
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 110
A contemporary update on pathology reporting for urinary bladder cancer. 110
Upregulation of Tissue and Urinary Nicotinamide N-Methyltransferase in Bladder Cancer: Potential for the Development of a Urine-Based Diagnostic Test. 109
Genitourinary cancers: molecular determinants for personalized therapies 109
PUNLMP or not PUNLMP? This is the problem. 108
Adipose cannabinoid CBI receptor and adiponectin expression correlate with microvascular damage in human-kidney 108
Morphological assessment of radical prostatectomy specimens. A protocol with clinical relevance. 107
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 107
Urothelial changes induced by therapeutic procedures for bladder cancer. A review. 106
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 106
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review 106
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis 106
alpha-Methylacyl coenzyme A racemase, Ki-67, and topoisomerase IIalpha in cystoprostatectomies with incidental prostate cancer 105
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 105
Biphasic Tumors of the Urogenital Tract: Selected Topics 105
Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT 104
[Nephrotic proteinuria with type 2 diabetes mellitus and autoimmune thyroiditis]. 104
Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups? 104
Prognostic role of Furhman grade and vascular endothelia growth factor in pT1a clear cell carcinoma in partial nephrectomy specimens 103
Changes in the normal-looking epithelium in prostates with PIN or cancer. 103
Epigenetic modifications and modulators in prostate cancer 102
Pseudocarcinomatous hyperplasia associated with primary lymphoma in the urinary bladder: a case report 101
Case diagnosis as positive identification in prostatic neoplasia 100
KIDNEY CANCER: NOT A SINGLE DISEASE. 99
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 99
Variants and Variations in Epithelial Renal Cell Tumors in Adults: The Pathologist's Point of View 99
Prostate cancer with cribriform morphology: diagnosis, aggressiveness, molecular pathology and possible relationships with intraductal carcinoma 99
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 97
Gleason grading of prostate carcinoma in needle biopsies vs. radical prostatectomy specimens. 97
Recurrent papillary urothelial neoplasm of low malignant potential. Subtle architectural disorder detected by quantitative analysis in DAXX-immunostained tissue sections. 97
Contemporary update on pathology-related issues on routine workup of prostate biopsy: sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry. 97
Pathology and molecular updates in tumors of the prostate: towards a personalized approach. 97
Combining radiotherapy with immunocheckpoint inhibitors or CAR-T in Renal Cell Carcinoma 97
Re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2016;70:738–9: Sentinel Lymph Nodes in Adipose Tissue Surrounding the Prostate Gland and Seminal Vesicles as Observed in Virtual Whole-mount Histologic Slides 97
ANCA-Associated Glomerulonephritis and Anti-Phospholipid Syndrome in a Patient with SARS-CoV-2 Infection: Just a Coincidence? 97
Changes produced in the urothelium by traditional and newer therapeutic procedures for bladder cancer. 96
Pathological definition and difficulties in assessing positive margins in radical prostatectomy specimens. 95
Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients 95
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 95
Apolipoprotein E expression in localized prostate cancers. 93
Immunohistochemical expression of Endothelin-1 and Endothelin-A and Endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. 93
pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging 93
Renal sarcoma associated with adult polycystic kidney disease. A case report and literature review. 92
Pathology of prostate cancer and focal therapy ('male lumpectomy'). 92
Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique 92
Molecular mechanisms in prostate cancer. A review. 92
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 92
Evaluation of prognostic factors in radical prostatectomy specimens with cancer 92
Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer. 90
Precise Morphologic Documentation with Large-format Histology of Clinical Findings in a Bladder Cancer Patient. 90
Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance. 90
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur. 90
Noninvasive urothelial neoplasms: which classification? 89
Molecular techniques and prostate cancer diagnostic. 89
Somatostatin receptor subtypes in hormone-refractory (castration-resistant) prostatic carcinoma. 89
A magnetic resonance imaging-based nomogram for predicting clinically significant prostate cancer at radical prostatectomy 88
Immunohistochemical detection and localization of somatostatin receptor subtypes in prostate tissue from patients with bladder outlet obstruction. 88
Elevation of c-FLIP in castrate-resistant prostate cancer antagonizes therapeutic response to androgen receptor-targeted therapy. 88
Handling of radical prostatectomy specimens: total embedding with whole mounts, with special reference to the Ancona experience. 87
Totale 11.297
Salva come PNG Salva come JPEG
Categoria #
all - tutte 102.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 102.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.778 0 0 0 0 0 314 321 180 288 263 297 115
2021/20221.661 117 392 55 93 11 109 47 108 106 132 107 384
2022/20233.227 282 248 202 277 224 840 8 202 738 17 125 64
2023/20241.857 312 56 90 268 317 427 26 41 13 44 31 232
2024/20253.689 389 311 190 89 116 109 350 176 925 257 352 425
2025/20264.035 530 704 752 1.023 855 171 0 0 0 0 0 0
Totale 20.792